Search results
Pneumococcal conjugate vaccine is a pneumococcal vaccine made with the conjugate vaccine method and used to protect infants, young children, and adults against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus).
The national vaccination program started vaccinating newborns in 2004 with the 7-valent pneumococcal conjugate vaccine (PCV 7). This was changed into the 13-valent conjugate (PCV 13) in 2011. The switch to the 10-valent conjugate (PCV 10) was made in July 2015 in Flanders and May 2016 in Wallonia . [ 10 ]
12 wrz 2024 · There are 4 pneumococcal vaccines available in the United States. Three are conjugate vaccines and 1 is a polysaccharide vaccine. Pneumococcal vaccines vary in how well they work and what serotypes, or strains, they protect against.
Pneumococcal conjugate vaccine helps protect against bacteria that cause pneumococcal disease. There are three pneumococcal conjugate vaccines (PCV13, PCV15, and PCV20). The different vaccines are recommended for different people based on age and medical status.
FDA licensed the first pneumococcal conjugate vaccine (PCV7) in 2000. A large clinical trial showed PCV7 reduced invasive disease caused by vaccine serotypes by 97%. Compared to unvaccinated children, children who received PCV7:
The first 7-valent pneumococcal polysaccharide conjugate vaccine (PCV7) developed in 2002 greatly reduced the rate of infections in children under 2 years of age and in unimmunized individuals in the same community through the herd effect. 10 – 12 In the decade after the introduction of PCV7, hospitalizations due to pneumonia have decreased ...
the 7-valent pneumococcal conjugate vaccine (PCV7) in children has resulted in a substantial reduction of invasive pneumococcal-related diseases and antibiotic resistance in older adults through reduced transmission of vaccine serotypes and development of herd immunity.
